AI Article Synopsis

  • The article reviews discussions from the Fifth International Forum for Liver MRI, emphasizing the use of gadoxetic acid-enhanced MRI in liver diagnostics.
  • Gadoxetic acid-enhanced MRI demonstrates high sensitivity and specificity in diagnosing liver tumors, particularly benefiting the characterization of borderline lesions during hepatobiliary phase imaging.
  • There is a call for standardized criteria to improve the interpretation of this imaging technique, especially for patients with cirrhosis or elevated risk for hepatocellular carcinoma.

Article Abstract

Objective: This article reviews topics discussed during the Fifth International Forum for Liver MRI (with a focus on gadoxetic acid-enhanced MRI), which was held in Munich, Germany, in September 2011.

Conclusion: Growing evidence shows that gadoxetic acid-enhanced MRI has high sensitivity and specificity for diagnosing liver tumors. Hepatobiliary phase imaging adds new information for the characterization of borderline lesions. However, there is a need to develop standardized criteria for interpretation of gadoxetic acid-enhanced MRI in patients with cirrhosis or other risk factors for hepatocellular carcinoma.

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.12.9491DOI Listing

Publication Analysis

Top Keywords

gadoxetic acid-enhanced
12
acid-enhanced mri
12
international forum
8
forum liver
8
liver mri
8
mri
5
consensus report
4
report international
4
mri objective
4
objective article
4

Similar Publications

Purpose: Vessels encapsulating tumor clusters (VETC) was implicated in the unfavourable prognosis of hepatocellular carcinoma (HCC). While potentially valuable for noninvasive evaluation, the proposed imaging criteria of VETC require external validation. This study aimed to evaluate the performance and prognostic value of these imaging criteria via CT and gadoxetic acid-enhanced MRI.

View Article and Find Full Text PDF

Comparisons of integrated slice-specific dynamic shimming EPI and single-shot EPI diffusion-weighted imaging of the liver.

Eur J Radiol

January 2025

Department of Radiology, The Second Xiangya Hospital, Central South University, No.139 Middle Renmin Road, Changsha, Hunan, 410011, China; Department of Radiology Quality Control Center, Changsha, Hunan Province, 410011, China; The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Institute of Health and Rehabilitation Science, Xi'an Jiaotong University, Xi'an 710049,China. Electronic address:

Purpose: To compare the quality of DWI images, signal loss of left hepatic lobe and diagnostic performance of apparent diffusion coefficient (ADC) values between SS-EPI and iShim-EPI in liver lesions.

Methods: Totally 142 patients were involved, images using SS-EPI and the prototype iShim-EPI were acquired before injection of gadoxetic acid-enhanced liver MRI.Image quality of demarcation of liver capsule, resolution, lesion distortion, artifacts, lesion confidence score, and signal loss in left hepatic lobe was assessed by two radiologists.

View Article and Find Full Text PDF

Background: Focal nodular hyperplasia (FNH)-like lesions are hyperplastic formations in patients with micronodular cirrhosis and a history of alcohol abuse. Although pathologically similar to hepatocellular carcinoma (HCC) lesions, they are benign. As such, it is important to develop methods to distinguish between FNH-like lesions and HCC.

View Article and Find Full Text PDF

Rationale And Objectives: Post-transarterial chemoembolization liver failure (PTLF) is a potentially fatal complication of transarterial chemoembolization (TACE). Accurate preoperative prediction of PTLF is crucial for improving patient outcomes. This study aimed to develop and validate a prediction model based on the functional liver imaging score (FLIS) to assess the risk of PTLF.

View Article and Find Full Text PDF

Purpose: This study compares the diagnostic efficacy of non-contrast abbreviated MRI protocols with Gadoxetic acid-enhanced abbreviated MRI for detecting colorectal liver metastasis (CRLM), focusing on lesion characterization and surveillance.

Methods: Ninety-four patients, including 55 with pathologically verified CRLM, were enrolled, totaling 422 lesions (287 metastatic, 135 benign). Two independent readers assessed three MRI protocols per patient: Protocol 1 included non-contrast sequences (T2-weighted turbo spin-echo, T1-weighted Dixon, diffusion-weighted imaging (DWI), and ADC mapping).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!